Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals

Document ID: FDA-2007-0614-0002

Comments

Total: 21
The Williamsburg Group, LLC - Comment
Posted : 01/30/2008     ID :FDA-2007-0614-0003     Agency : FDA

Feb 19,2008 11:59 PM ET
Agalloco & Associates - Comment
Posted : 02/10/2008     ID :FDA-2007-0614-0004     Agency : FDA

Feb 19,2008 11:59 PM ET
Allergan Pharmaceuticals - Comment
Posted : 02/10/2008     ID :FDA-2007-0614-0005     Agency : FDA

Feb 19,2008 11:59 PM ET
sanofi-aventis - Comment
Posted : 02/10/2008     ID :FDA-2007-0614-0006     Agency : FDA

Feb 19,2008 11:59 PM ET
Abbott Laboratories - Comment
Posted : 02/10/2008     ID :FDA-2007-0614-0007     Agency : FDA

Feb 19,2008 11:59 PM ET
Sanofi-aventis - Comment
Posted : 02/13/2008     ID :FDA-2007-0614-0008     Agency : FDA

Feb 19,2008 11:59 PM ET
Compressed Gas Association/GAWDA - Comment
Posted : 02/20/2008     ID :FDA-2007-0614-0010     Agency : FDA

Feb 19,2008 11:59 PM ET
Schering-Plough - Comment
Posted : 02/20/2008     ID :FDA-2007-0614-0011     Agency : FDA

Feb 19,2008 11:59 PM ET
Genzyme Corporation - Comment
Posted : 02/20/2008     ID :FDA-2007-0614-0012     Agency : FDA

Feb 19,2008 11:59 PM ET
Compressed Gas Association/GAWDA - Comment
Posted : 02/20/2008     ID :FDA-2007-0614-0013     Agency : FDA

Feb 19,2008 11:59 PM ET
Biotechnology Industry Organization - Comment
Posted : 02/20/2008     ID :FDA-2007-0614-0014     Agency : FDA

Feb 19,2008 11:59 PM ET
Immel Resources LLC - Comment
Posted : 02/22/2008     ID :FDA-2007-0614-0015     Agency : FDA

Feb 19,2008 11:59 PM ET
Parenteral Drug Association - Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0016     Agency : FDA

Feb 19,2008 11:59 PM ET
Plasma Protein Therapeutics Association - Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0017     Agency : FDA

Feb 19,2008 11:59 PM ET
Compressed Gas Association - Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0018     Agency : FDA

Feb 19,2008 11:59 PM ET
Immel Resources Inc., - Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0019     Agency : FDA

Feb 19,2008 11:59 PM ET
PhRMA - Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0020     Agency : FDA

Feb 19,2008 11:59 PM ET
GlaxoSmithKline- Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0021     Agency : FDA

Feb 19,2008 11:59 PM ET
Wyeth Pharmaceuticals - Comment
Posted : 02/26/2008     ID :FDA-2007-0614-0022     Agency : FDA

Feb 19,2008 11:59 PM ET
GlaxoSmithKline - Comment
Posted : 02/28/2008     ID :FDA-2007-0614-0023     Agency : FDA

Feb 19,2008 11:59 PM ET
CSSC, Inc. - Comment
Posted : 03/03/2008     ID :FDA-2007-0614-0024     Agency : FDA

Feb 19,2008 11:59 PM ET